Personal Injury Lawyers Eric S. Rothman & Sanders Viener Grossman
Practice Areas > Personal Injury > Defective Drugs > Celebrex Attorneys and Lawyers
News & Events
Personal Injury News
Personal Injury Alerts
Practice Areas
Personal Injury Medical Malpractice
Auto Accidents Construction Accidents
Social Security Worker's Compensation
Dog Bites Bankruptcy
Divorce Immigration

Defective Drugs
Avandia Fosamax Prexige Vioxx
Bextra Ortho Evra Risperdal Vytorin
Celebrex OxyContin Trasylol Yaz
Chantix Zetia

Defective Medical Devices
Surgical Mesh Patches
Contaminated Syringes
Heparin

Pacemakers/Defibrillators
Medtronic
Guidant

Defective Products
Tile Perfect Stand N' Seal

Neglect and Abuse
Nursing Homes
Lead Poisoning
Slip & Fall

Contact Us
Contact Methods
Address & Directions
By Telephone

Online Consultation
Online Contact Form
E-Mail Us

The Firm
Mission Statement
Firm History
Verdicts & Settlements
Our Attorneys
 

Personal Injury Lawyers

What Is Celebrex?
Celebrex is a Cox-2 inhibitor (non-steroidal anti-inflammatory) used to treat osteoarthritis, rheumatoid arthritis or management of acute pain in adults. It is similar to Vioxx which was voluntarily withdrawn from the market in September 2004 and Bextra which was withdrawn from the market in April 2005 due to its link to increased heart attack and stroke. Recent clinical studies of Celebrex have shown that the drug can cause an increased chance for patients to suffer from heart attacks, strokes, and other cardiovascular side effects. Celebrex has not been recalled, however, Pfizer has been urged to change the label to indicate the risks involved with the medication, including drug interactions.

 

 

 

 

 

 If you need to contact us about this matter, please click here for a free online consultation. 

 
Personal Injury HomePersonal Injury NewsPersonal Injury ContactsPersonal Injury SearchPersonal Injury Site Map
 
Persoanl Injury Home Personal Injury Law Offices of Eric S. Rothman & Sanders Viener Grossman - Persoanl Injury Home INJUREDus.com Powered by OCTwebs.